Q&A and Panel Discussion
6:40
Non Small Cell Lung Cancer
Q&A and Panel Discussion
Non Small Cell Lung Cancer Similar Videos
Similar Videos
-
Vivek Subbiah, MD The University of Texas MD Anderson Cancer Center 5Live #ASCO20
6:47
Key Insights on Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients on the LIBRETTO-001 trial.
-
Suresh Ramalingam, MD, FACP, FASCO; Winship Cancer Institute of Emory University; 5Live; #IASLC21
9:26
-
Andreas N. Saltos, MD; Moffitt Cancer Center; 5Live; #IASLC21
13:27
